Sir
We read with interest the recent paper by Pichon MF et al (1996) . We first noted that the following histopathological data had been used in this study: tumour classification, tumour grading, maximum tumour diameter and axillary lymph node status. These data were derived from the records of the pathological examination of 2257 tumorectomies or mastectomies. We then noticed that the histology slides had apparently not been reviewed by a panel of pathologists. Surely, this has become an indispensable way of ensuring a minimum of quality control in any multicentre study of this type. Being further aware that the authors of this paper did not include a single pathologist, we were dismayed by the complete lack of any reference to the several pathologists who had obviously contributed to this monumental series.
We wish to strongly urge editors and referees of international oncology journals, when reviewing multicentre studies primarily based on histopathological data, to ensure that such papers are adequately reviewed by a panel of pathologists and that the identity and affiliation of contributing or panelist pathologists are clearly indicated. Histopathological datareply
The aim of our study, using the data of medical records obtained under the conditions of current medical practice, was to evaluate the relationship between the results of quantitative measurements of hormone receptors in primary tumours and the occurrence of events during the monitoring of breast cancers. In French Cancer Centres, the diagnosis, treatment and monitoring of breast cancers is carried out by multidisciplinary teams made up of specialists who all contribute to the elaboration of the medical records common to the Institution. This paper did not purport to focus on histological correlations, which merely represent four out of nine criteria studied.
Consequently, we saw no case for a specific post-review of histological data, as the main criteria of this study, oestradiol and progesterone receptors, were permanently subject to quality control. This is common standard practice for all laboratories engaged in steroid receptor assays.
Furthermore, no recent similar studies include post-verification of histological data (Spyratos et al, 1992; Pujol et al, 1994; Romain et al, 1995 Romain et al, , 1996 .
In so far as no further work is required from any other speciality outside the present team, there is no justification for certain specialists rather than others in the list of authors. In addition, the majority of this series of patients' records has already been the object of previous publications to which pathologists were associated (more than 25 papers in all).
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